Recent development of mass spectrometer cleavable protein cross-linkers and algorithms for their spectral identification now permits large-scale cross-linking mass spectrometry (XL-MS).
Introduction
Protein-protein interactions mediate cellular functions including signaling, metabolism and cell differentiation. Disruption of protein-protein interactions can contribute to disease and defining how these interactions change across the proteome can provide important insights into pathogenic mechanisms and ultimately improved therapies. 1 Conventional methods to study protein-protein interactions involve large-scale affinity purification or separation of protein complexes combined with protein identification using mass spectrometry. [2] [3] [4] [5] [6] [7] These methods typically require ectopic expression of proteins, affinity tags for purification or separation of protein complexes from extracts and other non-physiological conditions, which can produce artifacts and disruption of of native protein interactions. In contrast, cross-linking mass spectrometry (XL-MS) relies on covalent labeling and cross-linking of proteins in physical proximity, thereby identifying physiologic protein-protein interactions. In addition, chemical cross-linking preserves direct or proximal protein-protein interactions, and can also identify transient interactions that occur dynamically during specific cell or developmental states. In addition, high-resolution mass spectrometry can identify direct sites of interaction between crosslinked amino acids, providing detailed spatial information for structural studies. [8] [9] Recently, development of collision-induced dissociation (CID) cleavable cross-linkers [10] [11] [12] [13] [14] and improvements in algorithms for cross-link peptide spectral analysis [15] [16] [17] [18] [19] has enabled proteinprotein interaction mapping of complex proteomes, including worm, 20-21 bacteria, [21] [22] [23] and human [15] [16] [24] [25] and various other organisms, 26 with hundreds-to-thousands of cross-links and protein-protein interactions. 16, 21 While cross-linking of cell extracts provides direct control of the reaction to label specific protein complexes, [15] [16] [20] [21] membrane-permeability of some cross-linking reagents enables cross-linking of protein complexes in live cells to define specific protein-protein interactions in situ.
To facilitate large-scale interaction proteomics, we sought to define the optimal methods for the isolation of cross-linked peptides from protein complexes labeled in situ, and to ensure their accurate identification using a target-decoy strategy adapted for cross-linking mass spectrometry.
Thus, we present optimized parameters for the use of the CID-cleavable cross-linker disuccinimidyl sulfoxide (DSSO) in situ. We found that higher-energy collisional dissociation (HCD) fragmentation produced as many cross-linked protein complex identifications as electron transfer dissociation (ETD) fragmentation using either whole proteome or focused target databases for cross-link peptide spectral matching. The use of multiple proteases significantly increased the coverage of protein-protein interactions maps. Importantly, the developed targetdecoy strategy allowed for explicit control of false discovery and optimization of sensitivity and specificity of protein interactions maps in cells in situ. Application of this approach to human chromatin labeled in live cells recapitulated known and revealed new protein interactions of nucleosomes and other chromatin-associated complexes. 6 DSSO dissolved in DMSO (1:1 protein amine:DSSO molar ratio). The solution was incubated at room temperature for 1 hour, before quenching by the addition of 1M ammonium bicarbonate buffer to a final concentration of 20 mM. The cross-linked protein was denatured by adding 50 µl of 6 M guanidine hydrochloride in 100 mM ammonium bicarbonate, pH 8, then reduced by adding 11 µl of 100 mM dithiothreitol at 56°C for 1hr and alkylated with 12 µl of 550 mM iodoacetamide at room temperature for 30 min in the dark. Alkylation was quenched by the addition of 13µl of 100 mM dithiothreitol and incubated at 56°C for 20 min. The solution was diluted with 50 mM ammonium bicarbonate solution, pH 8, for a final concentration of 0.2 M guanidine hydrochloride. For digestion with a single protease, either trypsin, chymotrypsin or GluC was added in 1:50 (enzyme:protein, w/w) concentration and incubated at 37°C for 18 hours.
For sequential digestion with LysC followed by trypsin, LysC was first added in 1:100 (enzyme:protein, w/w) concentration and incubated at 37°C for 8 hours. Trypsin was then added in 1:50 (enzyme:protein, w/w) concentration and incubated at 37°C for 18 hours. Digestion was stopped by the addition of formic acid to 1% (v/v) concentration. Peptides were then purified using solid phase extraction with C18 Macrospin columns according to manufacturer's instructions (Nest Group), and concentrated by vacuum centrifugation.
Protein cross-linking of live cells in situ and isolation of cross-linked peptides from
chromatin. HEK293T cells (50 million) were sedimented by centrifugation at 500 g and then suspended in 1 ml of hypotonic buffer (10 mM HEPES, pH 8, 10 mM sodium chloride, 1 mM magnesium chloride, 0.5 mM dithiothreitol, protease inhibitors). For cross-linking, 50 µl of 50 mM DSSO dissolved in DMSO was added and cells were incubated for 1 hour at 4°C. The reaction was then quenched by the addition of 50 µl of 500 mM Tris-HCl, pH 8. Cells were subsequently subjected to 15 strokes of Dounce homogenization and the solution was then 7 centrifuged for 15 min at 3300 g to isolate nuclei. Sedimented nuclei were then resuspended in 500 µl of 0.25 M sucrose, 10 mM magnesium chloride buffer and layered on top of a solution of 500 µl of 0.88 M sucrose, 0.05 mM magnesium chloride. The resultant mixture was centrifuged for 10 min at 1200 g. Purified nuclei were then resuspended in 1 ml of 10 mM HEPES, pH 7.4, 0.2 mM magnesium chloride solution and incubated on ice for 10 min to extract nucleoplasm.
The solution was then centrifuged for 20 min at 770 g. The pellet was next resuspended in 1 ml of 10 mM HEPES, pH 7.4, 500 mM sodium chloride, 0.2 mM magnesium chloride and incubated on ice for 10 min to extract bound proteins. The solution was then centrifuged for 20 min at 770 g. Next, the pellet was solubilized in 500 µl of detergent buffer (15 mM HEPES, pH 7.5, 500 mM sodium chloride, 1 mM dithiothreitol, 0.34 M sucrose, 10% glycerol, 0.5% v/v Triton X-100) and incubated on ice for 10 min. The solution was then layered on top of a 500 µl solution of 0.88 M sucrose, 0.05 mM magnesium chloride and centrifuged for 20 min at 3300 g to purify chromatin. The chromatin pellet was resuspended in 500 µl of 15 mM HEPES, pH 7.5, 15 mM sodium chloride, 60 mM potassium chloride, 5 mM magnesium chloride, 1 mM calcium chloride, 0.25 M sucrose and protease inhibitors (0.5 M AEBSF, 0.001 mM pepstatin, 0.01 mM bestatin and 0.1 mM leupeptin). The chromatin suspension was incubated at 37°C for 10 min.
Five units of micrococcal nuclease were subsequently added and incubated at 37°C for 1 hour.
The nuclease digestion was stopped by the addition of EDTA to a final concentration of 50 mM and the solution was centrifuged for 10 min at 18,000 g to remove the nuclear matrix. The supernatant containing cross-linked chromatin was then quantified using the BCA assay.
Cross-linked chromatin proteins were then purified by filter-aided sample preparation (FASP) using Sartorius Vivacon 500 with a 30,000 MW cut-off filter, as previously described. [27] [28] Briefly, 200 µg of protein was diluted 5-fold in urea buffer (8 M urea, 50 mM ammonium 8 bicarbonate, pH 8.0) and applied to the filter unit. Filter units were centrifuged at 14,000 g for 20 min. The membrane was then washed twice with 200 µl urea buffer by centrifugation at 14,000 g for 20 min. The membrane was then incubated with 200 µl of 100 mM dithiothreitol in urea buffer for 20 min at room temperature before centrifugation at 14,000 g for 20min. The proteins were then incubated with 200 µl of 100 mM iodoacetamide in urea buffer for 20 min at room temperature in the dark before centrifugation at 14,000 g for 20 min. The membrane was washed twice more with urea buffer then once with 200 µl of 50 mM ammonium bicarbonate, pH 8.
Proteins retained on the membrane were then digested with trypsin at 1:50 (enzyme:protein, w/w) concentration at 37°C for 18 hours. Digested peptides were collected by centrifugation at 14,000 g for 20 min. Peptides were then purified using solid phase extraction with C18 Macrospin columns according to manufacturer's instructions (Nest Group). The purified peptides were concentrated by vacuum centrifugation and resuspended in 100 µl of 5% acetonitrile, 0.1% formic acid. The peptides were then injected onto the strong cation exchange (SCX) column (Protein Pak Hi-Res SP 7µm 4.6 x 100mm, Water) at a flow rate of 0.5 ml/min with a column temperature of 30°C using the Alliance HPLC system (Waters). Gradient was run with 5% acetonitrile and 0.1% formic acid in water for solvent A and 1 M potassium chloride in 5% acetonitrile and 0.1% formic acid in water for solvent B. Column gradient was set as follows: 0-3 min (0% B); 3-33 min (0-10% B); 33-43 min (10-100% B); 43-60 min (100% B); 60-70 min (100-0% B); 70-90 min (0% B). Six fractions were collected from 38 to 60 min and purified using solid phase extraction with C18 Macrospin columns according to manufacturer's instructions (Nest Group). Peptides were concentrated by vacuum centrifugation and then stored at -20°C before analysis.
Liquid chromatography and nanoelectrospray mass spectrometry. Cross-linked peptides
were separated by reverse phase nanoflow liquid chromatography (EKspert nanoLC 425, Ekisgent) coupled to the Orbitrap Fusion mass spectrometer (Thermo). Cross-linked BSA peptides and HEK293T peptides were resuspended in 0.1% formic acid in water (v/v). For crosslinked BSA peptides, 1 µg of peptide was injected for analysis. For cross-linked BSA peptides mixed with non-cross-linked HEK293T peptides in 1:1 (w/w) ratio, 1 µg of total peptide was analyzed. For SCX fractions of cross-linked chromatin, peptides were resuspended in 20 µl of 0.1% formic acid in water (v/v) and 0.5 µg of peptides were analyzed.
For liquid chromatography, a trap-elute system was used, as described previously. 29 Reverse phase columns were fabricated as previously described. 30 Trap columns were fabricated by packing Poros R2 10µm C18 particles (Life Technologies) into 4 cm fritted capillaries with internal diameters of 150 µm. Reverse phase columns were fabricated by packing Reprosil 1.9 µm silica C18 particles into 40 cm fritted capillaries with internal diameters of 75 µm. Peptides were resolved over a 90 min gradient from 5% to 40% acetonitrile and ionized using the DPV-565 Picoview ion source (New Objective) operated with the ionization voltage of 1700 V.
Custom electrospray emitters were fabricated as previously described. 31 For mass spectrometry, four different acquisition methods were used: 1) CID-MS2/HCD-MS2, 2) CID-MS2/ETD-MS2, 3) CID-MS2/EThcD-MS2, 4) CID-MS2/HCD-MS3, where HCD is the higher-energy collisional dissociation, ETD is electron transfer dissociation, and EThcD is the hybrid electron transfer with supplemental activation by higher energy collision dissociation. For with the sequences of common contaminant proteins from cRAP. 33 Mass spectral analysis parameters included 2 maximum allowed missed cleavages, minimum peptide length of 5 and 4 maximum variable modifications: methionine oxidation, hydrolysis of lysyl-DSSO by water, and lysyl-DSSO-Tris adduct. Precursor mass tolerance was set at 10 ppm with fragment mass tolerance of 20 ppm and 0.5 Da for Orbitrap and ion trap spectra, respectively. Cysteine carbamidomethylation was set as fixed modification. A 1% false discovery rate (FDR) was set for cross-link peptide spectra matching with minimum score threshold set at 0 using the Percolator algorithm. 34 Peptide spectral matches and their scores were analyzed using R scripts to concatenate cross-links identified from biological replicates (https://github.com/kentsisresearchgroup/R-script-for-XLMS-data-analysis). For histone proteins, peptides that could be identified as exclusively belonging to specific isoforms were marked with their specific isoform protein name or gene name. Proteins that could be mapped to multiple isoforms were labeled with the family protein or gene name, e.g. peptides that could belong to histone isoforms H3.1, H3.2 or H3.3 were labeled as histone H3 peptides. Bar graphs and scatter plots were plotted using Origin 2018 (Microcal). Venn diagrams were made with Venny version 2.1. 35 Peptide cross-link sequences were visualized using xiNET. 36 Atomic resolution structures were visualized with UCSF Chimera 37 version 1.12 and cross-links were mapped using Xlink analyzer. 38 Protein-protein interaction maps were made with Cytoscape version 3.6.0. 39 Mass spectrometry raw files and search results are publicly available through the ProteomeXchange data repository via the PRIDE database. described. [15] [16] 19 To further advance our ability to control the sensitivity and specificity of cross-linked peptide discovery, we reasoned that discrimination of true and false positive peptide-spectral matches can be achieved using target-decoy strategies tailored specifically to cross-linked peptides. To model a typical XL-MS sample, containing both cross-linked and non-cross-linked peptides, we cross-linked purified bovine serum albumin (BSA), which was subsequently diluted in noncross-linked proteins extracted from human HEK293T cells ( Figure 1A ). BSA is a widely used model protein for mass spectrometry that spontaneously oligomerizes in solution. [40] [41] Insofar as Figure 1B ). Despite applying a 1% FDR threshold for peptide-spectral matching using Percolator, 34 we observed a substantial number of apparently incorrectly matched cross-linked peptide spectra. For example, for CID-MS2/HCD-MS2 fragmentation, 173 of 291 (59%) of cross-links matched were mapped to human proteins that were not DSSO cross-linked, indicating incorrect CSMs. Manual inspection of representative spectra confirmed that these apparent incorrect matches were due to either incomplete fragmentation spectrum of one of the peptides in the pair or relatively low signal intensity of the diagnostic DSSO fragment ions. We confirmed that none of the examined spectra from apparently incorrect matches exhibited fragment ions consistent with albumin peptide sequences. Finally, we also verified that none of the mis-matched spectra were due to the incomplete DSSO cross-linking reaction due to spectra with single site DSSO adducts.
Results and Discussion

Calibration of cross-link peptide-spectra matching (CSM) scores to control sensitivity
We reasoned that such false cross-linked peptide-spectral matches can be distinguished by their relative cross-link peptide-spectra matching (CSM) scores, as defined by the current XlinkX algorithm ( Figure 1B ). [15] [16] Thus, we fit the observed CSM score distributions to a linear mixture of two Gaussian functions, producing two modes corresponding to apparently true and false matches ( Figure 1C ). Consequently, for the observed spectra using the four acquisition methods tested, this led to a CSM score threshold of 100 to achieve 1% FDR at the peptide level ( Figure   1D ). In addition, we defined a CSM score threshold of 74 for improved sensitivity at a more relaxed (10%) peptide-level FDR. These empiric CSM score thresholds should be generalizable to other experiments, insofar as the physicochemical properties of the peptide analyzed are adequately approximated by BSA and human proteins ( Figures S-1) .
Importantly, the use of these CSM score thresholds reduced the number of false non-BSA crosslinks matched to non-cross-linked human proteins from 58 to 3 ( Figure 1E ). In addition, we analyzed the identified BSA cross-links with respect to the high-resolution atomic-level structure of BSA (PDB ID 4f5s). 42 Consistently, the use of CSM score thresholds eliminated cross-links between lysine residues that are farther than 23 Å (the length of the DSSO cross-linker), while retaining cross-link matches with the expected physical distances ( Figure 1F ). These results demonstrate the need for controlling the false identifications inherent in the statistical spectral matching for large-scale cross-linking mass spectrometry proteomics, and provide a facile means to do so using a target-decoy spectral matching strategy adapted for cross-linking mass spectrometry.
Improved cross-linked peptide identification using CID-MS2/HCD-MS2 fragmentation.
Comparison of CID, HCD and ETD fragmentation of linear non-cross-linked peptides indicates
that the efficiency of each fragmentation method, and therefore their capacity to produce optimal fragment ion spectra, depends on the specific physicochemical properties of fragmented peptides 43 . For example, ETD exhibits reduced fragmentation efficiency for larger m/z peptides. 44 Previous studies of non-cleavable cross-linkers found that HCD fragmentation suggesting that there is some orthogonality in coverage between these two fragmentation methods ( Figure 2D ). Comparison between CID-MS2/HCD-MS2 and CID-MS2/ETD-MS2 methods showed an overlap between the types of cross-links identified, with 32 out of 59 (54%) and 19 out of 35 (54%) shared cross-links identified for cross-linked BSA peptides and crosslinked BSA peptides mixed with the non-cross-linked proteome, respectively. Comparison of identified cross-linked peptides showed relatively shorter peptide length, lower precursor m/z and lower cross-linked peptide identifications across all charge states obtained by ETD fragmentation 16 compared to that obtained by HCD fragmentation (Figure S-1 ), in line with prior observations. 44 A substantial number (10-30%) of cross-linked peptides were identified exclusively by either ETD or HCD fragmentation methods ( Figure 2B, 2D ), suggesting some orthogonality between the two fragmentation methods. Naturally, these results are generalizable to other complex proteomes largely for cross-linked peptides that are adequately modeled by cross-linked BSA.
In all, these results indicate that CID-MS2/HCD-MS2 fragmentation can yield the highest 
Sample-specific search target databases for identification of protein-protein interactions by
XL-MS. While the use of a mass spectrometer cleavable cross-linkers reduces the database search space and time as compared to non-cleavable cross-linkers, 15 the use of sample-specific search databases can improve the sensitivity of mass spectral matching. [46] [47] [48] [49] Since cross-linking mass spectrometry is often used for the analysis of specific purified protein complexes, we examined the effects of using sample-specific as compared to proteome-wide search databases.
Thus, we generated search databases based on the BSA sequence alone, or a concatenated database containing BSA plus the human reference proteome, supplemented with common proteomic contaminants from cRAP. 33 We observed an average of 43 BSA cross-links across 3 biological replicates when searching against either the BSA-specific or reference human proteome databases ( Figure 2E) . For cross-linked BSA peptides mixed with the non-cross-linked proteome, we found an average of 21 and 22 BSA cross-links from 3 biological replicates when searching against the BSA-specific database or BSA plus reference human proteome databases, respectively ( Figure 2E ). This suggests that the database size and composition do not affect the sensitivity of cross-link identification per se ( Figure 2F ). With the BSA-specific database excluding any possible false matches, we observed a significant reduction in false matches of cross-linked BSA to non-cross-linked human proteins, when using the BSA-specific database, as would be expected from first principle considerations (0 as compared to 3, respectively, p = 0.048, Figure 2E ).
Diverse sequence-specific proteases to expand the coverage and density of DSSO XL-MS
protein interaction maps. We reasoned that the DSSO reaction with lysine residues reduces the accessibility of cross-linked peptides for protease digestion, thus reducing the identification of tryptic cross-linked peptides. Consistent with this, we found substantially more unique crosslinks identified from the sequential protease digest using LysC endoprotease followed by trypsin, as compared to that of trypsin alone (90 versus 18, respectively, Figure 3A ). This combined LysC and trypsin digestion produced cross-link sites across the whole BSA protein sequence ( Figure 3C ), suggesting that accessibility of amino acid sites for protease digestion affects crosslink peptide identification. For linear non cross-linked peptides, additional sequence-specific proteases are known to identify additional peptide sequences, thus improving protein sequence coverage. [50] [51] [52] Hence, we compared three different digestion methods using additional proteases specific to non-lysine amino acids: 1) sequential digestion with LysC followed by trypsin, 2)
GluC endoprotease, and 3) chymotrypsin. Combined LysC and trypsin digestion identified the highest number of unique cross-linked sites, as compared to GluC and chymotrypsin digestions (90 versus 69 and 56, respectively, p < 0.01 and p < 0.01, Figure 3B ). We observed a minor overlap among these cross-linked sites, with the majority of identified sites involving different BSA residues ( Figure 3C) , presumably due to the differences in susceptibility to enzymatic endoproteolysis. 50 On average, cross-linked peptides identified by GluC digestion were more highly charged, as compared to those identified by chymotrypsin or trypsin ( Figure S-2) . Thus, the use of multiple, non-lysine-dependent proteases can expand the coverage and density of DSSO XL-MS protein interaction maps.
Native chromatin protein-protein interactions identified using cross-linking mass spectrometry in situ.
Having identified a robust means to control the sensitivity and specificity of large-scale cross-linking mass spectrometry, we sought to examine the ability of DSSO to label native protein complexes in live human cells. We chose to study protein-protein interactions of human chromatin in situ, given its abundance and prominent functions in the regulation of cell growth and development. We optimized a protocol to label live human HEK293T cells with DSSO (see Methods). Chromatin proteins were extracted from purified nuclei by sucrose sedimentation, followed by sequential salt, detergent, and micrococcal nuclease digestion to release chromatin bound proteins. [53] [54] [55] We used SDS-PAGE followed by silver staining to confirm the presence of reduced mobility protein complexes upon DSSO crosslinking, as compared to mock-treated cells ( Figure 4A ). Likewise, we used Western immunoblotting to verify the isolation of histone-containing chromatin complexes, as opposed to nucleoplasmic or cytoplasmic proteins, as assessed by histone H3, BRG1, and GAPDH, respectively ( Figure 4B ).
Analysis of the cross-linked chromatin fraction identified 1,277 unique cross-linked peptides
from three biological replicates, with 384 unique cross-linked peptides at least two out of three biological replicates (Table S-1) . Of these, 189 (49%) of cross-linked peptides were between two different proteins, while 195 (515) were interactions within the same proteins, with 95 of these interactions also represented in the current BioGRID and CORUM protein-protein interaction databases. [56] [57] [58] [59] In agreement with the empirically determined CSM score thresholds for identifying high-confidence protein-protein interactions, we observed that all 8 cross-links involving residues in the nucleosome histone core can be mapped onto the high-resolution, atomic-level structure of the human nucleosome, 60 consistent with the 23 Å distance constraint based on the length of the DSSO linker ( Figure 4C ). Likewise, protein-protein interactions involving the core histone proteins captured many known histone-histone interactions, such as those between the core histone H2B and H2A, H4 and H3 histones ( Figure 4C) . Notably, we observed 46 cross-links involving the histone tails, which were not visualized in the isolated nucleosome core structure in vitro, 60 suggesting that they are in fact organized and bound to specific cofactors in situ. In particular, we observed numerous cross-links involving histone H2B K5 and histone H3 K4 and K18, which were also found in a recent study. 61 Notably, using labeling of protein complexes in situ, we observed numerous previously unrecognized interactions. For example, we found numerous cross-links between the HMGN1 and HMGN2 proteins with histone H2B and histone H1.2 ( Figure 5D & E) . HMGN1 and HMGN2 are known to regulate chromatin configuration, 62 which can involve phosphorylation of histone H2A and histone H3. [63] [64] Our findings indicate that HMGN1 can also bind directly to K120 of H2B, and HMGN2 can bind directly to K206 of H1.2 in the context of native chromatin in situ, which may provide the sought-after mechanism to explain its structural effects on 20 chromatin configuration directly. [65] [66] Likewise, we observed new protein-protein interactions involving ADARB1 with histone H2B, and centriolin/CNTRL with histone H3. This suggests that these two proteins may have unanticipated functions on DNA and/or chromatin. Similarly, we observed numerous cross-links to the linker histone H1, including PHRF1, ZNF786, PDE1C, and SEPT1, suggesting that these proteins may have additional structural chromatin functions, possibly in stabilizing or regulating histone linker-dependent higher-order chromatin conformations in situ ( Figure 4E ).
Lastly, we found numerous chromatin interactions of proteins involved in DNA damage repair and ribonucleoproteins. For instance, we observed cross-links from PARP1 to K108 and K116 of histone H2B, in addition to 17 intra-protein PARP1 cross-links ( Figure 5A ). We confirmed that 8 of 17 detected PARP1 cross-links could be mapped onto its high-resolution structure (PDB ID 4dqy), 67 as bound to a DNA double stranded break site ( Figure 5B ). PARP1 is known to selfassociate, [68] [69] and our findings provide a direct mechanism of chromatin recruitment, linking PARP1 to histone H2B. This interaction may affect PARP1 self-association and DNA recognition and/or contribute to chromatin remodeling associated with DNA damage repair. [70] [71] [72] [73] [74] Similarly, we found numerous cross-links among the heterogenous nuclear ribonucleoproteins hnRNPs and chromatin ( Figure 5C ). This included known interactions between hnRNPA1 and hnRNP2B, and between hnRNPA1 and hnRNPA3, providing specific structural details on their physical proximity. [75] [76] In addition, we observed direct interactions between DNA ligase LIG4 and hnRNPU proteins with histone H2B, raising the possibility that chromatin and hnRNP recruitment can regulate repair of DNA double-strand breaks. 77 While these interactions will require dedicated future studies to confirm and establish their functions, these results indicate 21 that native chromatin protein-protein interactions can be identified by using cross-linking mass spectrometry in situ.
Conclusions and Future Directions
Here, we sought to define the optimal methods for the isolation of cross-linked peptides from protein complexes labeled in situ, and to ensure their accurate identification using a target-decoy strategy adapted for cross-linking mass spectrometry. The presented generalized linear mixture model offers a facile means to control sensitivity and specificity based on a target-decoy spectral matching strategy adapted for cross-linking mass spectrometry. Using this approach, additional mixtures can be prepared in the future to model distinct protein complexes and peptide sequences, such as those containing particular chemical modifications. We also anticipate that improved scoring functions incorporating fragmentation features of specific cross-linkers as a function of fragmentation and isolation methods, such as the diagnostic sulfoxide fragment ion doublet in DSSO, as well as the use of isotopically labeled heavy and light cross-linkers to label experimental and control samples, can be used to improve the sensitivity and specificity of crosslinked peptide spectral identification. [78] [79] [80] Likewise, for the study of specific complexes, samplespecific target databases can be used to improve spectral matching accuracy. Importantly, we found that the density and coverage of protein-protein interaction maps can be significantly improved through the use of diverse sequence-specific proteases, and complex cross-linked mixtures can be effectively analyzed using relatively fast CID-MS2/HCD-MS2 fragmentation methods. Lastly, our studies of native human chromatin labeled in live cells recapitulated known and revealed new protein interactions of nucleosomes and other chromatin-associated complexes.
In all, this approach should facilitate the discovery and definition of protein-protein complexes in vivo, both in health and disease. 
